A proposal for validation of antibodies.
Science for Life Laboratory, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
Mathias
0000-0002-4858-8056
M
Uhlen
Center for Research in Biological Systems, University of California at San Diego, San Diego, California, USA.
Anita
A
Bandrowski
Proteomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
Steven
S
Carr
Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Aled
A
Edwards
Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Jan
J
Ellenberg
Science for Life Laboratory, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
Emma
E
Lundberg
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
David L
DL
Rimm
Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Henry
H
Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Tara
T
Hiltke
Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Michael
M
Snyder
Biofluid Biomarker Center, Niigata University, Niigata, Japan.
Tadashi
T
Yamamoto
D000906:Antibodies / Q000276:immunology*; D000941:Antigens / Q000276:immunology*; D006801:Humans; D015203:Reproducibility of Results; D054928:Validation Studies as Topic
D000906:Antibodies; D000941:Antigens